Trinity Total Assets from 2010 to 2025

TRIB Stock

USD 0.77 0.05 6.59%

Trinity Biotech's Total Assets are decreasing over the years with slightly volatile fluctuation. Total Assets are expected to dwindle to about 64.9 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

1993-12-31

Previous Quarter

94.4 M

Current Value

97.4 M

Quarterly Volatility

82.7 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Trinity Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Trinity Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.6 M, Total Revenue of 78.6 M or Gross Profit of 35.1 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.0095 or Days Sales Outstanding of 88.98. Trinity financial statements analysis is a perfect complement when working with Trinity Biotech Valuation or Volatility modules.

Check out the analysis of Trinity Biotech Correlation against competitors.

Latest Trinity Biotech's Total Assets Growth Pattern

Below is the plot of the Total Assets of Trinity Biotech plc over the last few years. Total assets refers to the total amount of Trinity Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Trinity Biotech plc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Trinity Biotech's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Trinity Biotech's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 59.44 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Trinity Total Assets Regression Statistics

	Arithmetic Mean	153,794,874
	Geometric Mean	116,651,783
	Coefficient Of Variation	58.30
	Mean Deviation	70,354,235
	Median	151,235,000
	Standard Deviation	89,654,813
	Sample Variance	8038T
	Range	354.1M
	R-Value	(0.44)
	Mean Square Error	6979.8T
	R-Squared	0.19
	Significance	0.09
	Slope	(8,198,442)
	Total Sum of Squares	120569.8T

Trinity Total Assets History

	2025	64.9 M
	2024	68.4 M
	2023	59.4 M
	2022	92.1 M
	2021	118.9 M
	2020	130.4 M
	2019	131.1 M

Other Fundumenentals of Trinity Biotech plc

Intangibles To Total Assets

Trinity Biotech Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Good Will	Long Term Debt	Property Plant Equipment	Current Deferred Revenue	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.87	-0.48	0.87	0.82	0.73	0.3	0.86	-0.05	0.94	-0.29	0.83	0.15	0.81	-0.38	0.43	0.65	0.74	0.4	0.53	0.18	0.36	0.65	0.55	-0.51
Total Stockholder Equity	0.87		-0.82	0.99	0.68	0.51	-0.2	0.65	-0.11	0.85	-0.44	0.91	-0.34	0.75	-0.26	0.77	0.89	0.89	0.77	0.22	0.19	0.38	0.8	0.72	-0.54
Net Debt	-0.48	-0.82		-0.81	-0.32	-0.08	0.61	-0.37	0.19	-0.42	0.52	-0.61	0.66	-0.35	0.04	-0.88	-0.87	-0.76	-0.87	0.07	-0.22	-0.36	-0.77	-0.72	0.44
Retained Earnings	0.87	0.99	-0.81		0.68	0.52	-0.18	0.66	-0.04	0.83	-0.52	0.91	-0.34	0.74	-0.2	0.77	0.88	0.88	0.77	0.23	0.26	0.44	0.82	0.7	-0.62
Accounts Payable	0.82	0.68	-0.32	0.68		0.75	0.33	0.68	-0.15	0.78	-0.34	0.67	0.22	0.6	-0.41	0.2	0.5	0.52	0.16	0.44	0.11	0.39	0.65	0.59	-0.56
Net Receivables	0.73	0.51	-0.08	0.52	0.75		0.44	0.71	-0.1	0.65	0.0	0.48	0.32	0.55	-0.45	-0.03	0.19	0.25	-0.01	0.23	-0.09	0.12	0.27	0.3	-0.38
Total Liab	0.3	-0.2	0.61	-0.18	0.33	0.44		0.42	0.12	0.2	0.2	-0.1	0.96	0.12	-0.22	-0.63	-0.42	-0.24	-0.67	0.62	0.1	0.1	-0.22	-0.29	0.02
Total Current Assets	0.86	0.65	-0.37	0.66	0.68	0.71	0.42		-0.07	0.66	-0.17	0.47	0.34	0.56	-0.4	0.21	0.43	0.5	0.16	0.62	0.01	0.18	0.5	0.43	-0.48
Short Term Debt	-0.05	-0.11	0.19	-0.04	-0.15	-0.1	0.12	-0.07		-0.07	-0.1	-0.01	-0.05	-0.12	-0.12	-0.14	-0.23	-0.18	-0.11	0.33	0.22	0.11	-0.1	-0.61	-0.17
Intangible Assets	0.94	0.85	-0.42	0.83	0.78	0.65	0.2	0.66	-0.07		-0.22	0.91	0.03	0.9	-0.38	0.48	0.66	0.79	0.47	0.41	0.13	0.27	0.59	0.53	-0.4
Common Stock	-0.29	-0.44	0.52	-0.52	-0.34	0.0	0.2	-0.17	-0.1	-0.22		-0.48	0.23	-0.16	-0.52	-0.52	-0.65	-0.54	-0.54	-0.2	-0.43	-0.7	-0.83	-0.57	0.83
Good Will	0.83	0.91	-0.61	0.91	0.67	0.48	-0.1	0.47	-0.01	0.91	-0.48		-0.28	0.82	-0.12	0.7	0.82	0.86	0.72	0.23	0.26	0.43	0.75	0.63	-0.55
Long Term Debt	0.15	-0.34	0.66	-0.34	0.22	0.32	0.96	0.34	-0.05	0.03	0.23	-0.28		-0.03	-0.13	-0.7	-0.48	-0.32	-0.74	0.56	-0.05	0.01	-0.28	-0.25	0.09
Property Plant Equipment	0.81	0.75	-0.35	0.74	0.6	0.55	0.12	0.56	-0.12	0.9	-0.16	0.82	-0.03		-0.2	0.55	0.63	0.77	0.49	0.29	0.1	0.09	0.44	0.47	-0.37
Current Deferred Revenue	-0.38	-0.26	0.04	-0.2	-0.41	-0.45	-0.22	-0.4	-0.12	-0.38	-0.52	-0.12	-0.13	-0.2		0.16	0.09	-0.02	0.16	-0.2	0.18	0.16	0.13	0.18	-0.24
Treasury Stock	0.43	0.77	-0.88	0.77	0.2	-0.03	-0.63	0.21	-0.14	0.48	-0.52	0.7	-0.7	0.55	0.16		0.91	0.85	0.96	-0.06	0.23	0.23	0.7	0.67	-0.39
Net Tangible Assets	0.65	0.89	-0.87	0.88	0.5	0.19	-0.42	0.43	-0.23	0.66	-0.65	0.82	-0.48	0.63	0.09	0.91		0.95	0.89	0.14	0.16	0.37	0.89	0.84	-0.59
Deferred Long Term Liab	0.74	0.89	-0.76	0.88	0.52	0.25	-0.24	0.5	-0.18	0.79	-0.54	0.86	-0.32	0.77	-0.02	0.85	0.95		0.83	0.27	0.2	0.35	0.81	0.74	-0.51
Long Term Investments	0.4	0.77	-0.87	0.77	0.16	-0.01	-0.67	0.16	-0.11	0.47	-0.54	0.72	-0.74	0.49	0.16	0.96	0.89	0.83		-0.17	0.2	0.28	0.68	0.63	-0.41
Short Long Term Debt	0.53	0.22	0.07	0.23	0.44	0.23	0.62	0.62	0.33	0.41	-0.2	0.23	0.56	0.29	-0.2	-0.06	0.14	0.27	-0.17		0.18	0.21	0.32	0.04	-0.32
Long Term Debt Total	0.18	0.19	-0.22	0.26	0.11	-0.09	0.1	0.01	0.22	0.13	-0.43	0.26	-0.05	0.1	0.18	0.23	0.16	0.2	0.2	0.18		0.78	0.25	0.04	-0.15
Capital Surpluse	0.36	0.38	-0.36	0.44	0.39	0.12	0.1	0.18	0.11	0.27	-0.7	0.43	0.01	0.09	0.16	0.23	0.37	0.35	0.28	0.21	0.78		0.58	0.32	-0.45
Net Invested Capital	0.65	0.8	-0.77	0.82	0.65	0.27	-0.22	0.5	-0.1	0.59	-0.83	0.75	-0.28	0.44	0.13	0.7	0.89	0.81	0.68	0.32	0.25	0.58		0.83	-0.79
Net Working Capital	0.55	0.72	-0.72	0.7	0.59	0.3	-0.29	0.43	-0.61	0.53	-0.57	0.63	-0.25	0.47	0.18	0.67	0.84	0.74	0.63	0.04	0.04	0.32	0.83		-0.55
Capital Stock	-0.51	-0.54	0.44	-0.62	-0.56	-0.38	0.02	-0.48	-0.17	-0.4	0.83	-0.55	0.09	-0.37	-0.24	-0.39	-0.59	-0.51	-0.41	-0.32	-0.15	-0.45	-0.79	-0.55

Click cells to compare fundamentals

About Trinity Biotech Financial Statements

Trinity Biotech stakeholders use historical fundamental indicators, such as Trinity Biotech's Total Assets, to determine how well the company is positioned to perform in the future. Although Trinity Biotech investors may analyze each financial statement separately, they are all interrelated. For example, changes in Trinity Biotech's assets and liabilities are reflected in the revenues and expenses on Trinity Biotech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Trinity Biotech plc. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	68.4 M	64.9 M
Intangibles To Total Assets	0.25	0.29

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

When determining whether Trinity Biotech plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Trinity Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Trinity Biotech Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Trinity Biotech Plc Stock:

How To Invest In Trinity

Details

Is Trinity Stock a good investment?

Details

What is Trinity Biotech's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Trinity Biotech Correlation against competitors.

You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.77)

Earnings Share

(2.16)

Revenue Per Share

6.497

Quarterly Revenue Growth

0.032

Return On Assets

(0.08)

The market value of Trinity Biotech plc is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Biotech's value that differs from its market value or its book value, called intrinsic value, which is Trinity Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Biotech's market value can be influenced by many factors that don't directly affect Trinity Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Trinity Total Assets from 2010 to 2025

Latest Trinity Biotech's Total Assets Growth Pattern

Trinity Total Assets Regression Statistics

Trinity Total Assets History

Other Fundumenentals of Trinity Biotech plc

Trinity Biotech Total Assets component correlations

About Trinity Biotech Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY